VRAX · NASDAQ
Virax Biolabs Group (VRAX) Stock Price & Fundamentals
Virax Biolabs Group (VRAX) closed at $1,320.68 on Oct 9, 2026, down 1.35% from the previous close of $1,338.70.
Share price, past year
1Y +50.16%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,320.68 |
| Sep 30, 2026 | $1,310.50 |
| Aug 31, 2026 | $1,218.68 |
| Jul 31, 2026 | $1,132.65 |
| Jun 30, 2026 | $1,112.48 |
| May 29, 2026 | $1,106.35 |
| Apr 30, 2026 | $1,093.23 |
| Mar 31, 2026 | $1,086.89 |
| Feb 27, 2026 | $1,074.75 |
| Jan 30, 2026 | $996.06 |
| Dec 31, 2025 | $943.93 |
| Nov 28, 2025 | $955.52 |
| Oct 31, 2025 | $932.37 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 579.2K
- Dividend yield
- —
- 52-week range
- $879.52 – $1,353.58
Market cap, P/E and dividend yield aren't shown for Virax Biolabs Group yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
Virax Biolabs Group reported revenue of $6.33K for fiscal 2025, down 95.95% from fiscal 2024.
Virax Biolabs Group reported a net loss of $6.06M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Mar 31, 2025 | $6.33K | −96.0% | −$6.06M | −95,739.2% | −$1.62 | −$5.17M |
| FY2024ended Mar 31, 2024 | $156.42K | +1,727.1% | −$6.73M | −4,304.8% | −$3.36 | −$7.20M |
| FY2023ended Mar 31, 2023 | $8.56K | — | −$5.46M | −63,748.3% | −$5.13 | — |
| FY2022ended Mar 31, 2022 | $0.00 | −100.0% | −$1.71M | — | −$1.79 | — |
| FY2021ended Mar 31, 2021 | $123.82K | — | −$650.98K | −525.8% | — | — |
Company profile
- Name
- Virax Biolabs Group Ltd
- Ticker
- VRAX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Biocity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, X0 ML1 5UH
- Incorporated in
- E9
- Fiscal year ends
- March
- SEC CIK
- 0001885827
Recent SEC filings
- Jul 6, 2026
- Jul 2, 2025
- Aug 20, 2024
- Jun 14, 2023
- Aug 12, 2022
Frequently asked questions
What is Virax Biolabs Group's stock price?
Virax Biolabs Group (VRAX) closed at $1,320.68 on Oct 9, 2026, down 1.35% from the previous close of $1,338.70.
How much revenue does Virax Biolabs Group make?
Virax Biolabs Group reported revenue of $6.33K for fiscal 2025, down 95.95% from fiscal 2024.
Sources and methodology
Fundamentals come from Virax Biolabs Group Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures